Local administration of cytostatic drugs enhances delayed-type hypersensitivity to Sendai virus in mice.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Clinical Immunology and Immunopathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0090-1229(90)90015-IPMID 2152858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of various cytostatic drugs as local immunotherapeutic agents

  2004cited by this paper
• Virus-induced delayed-type hypersensitivity reaction is sequentially mediated by CD8+ and CD4+ T lymphocytes.

  1989cited by this paper
• T cell mediated immunity in virus infection.

  1987cited by this paper
• Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations

  1986cited by this paper
• The immunoaugmenting effects of cancer chemotherapeutic agents.

  1986cited by this paper
• The host response to herpes simplex virus.

  1985cited by this paper
• Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells.

  1985cited by this paper
• Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection

  1985cited by this paper
• Viral immunopathology.

  1985cited by this paper
• Induction of delayed-type hypersensitivity to measles virus in mice.

  1984cited by this paper
• Inhibition of the development of suppressor cells in culture by 4-hydroperoxycyclophosphamide

  1984cited by this paper
• Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.

  1984cited by this paper
• Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice.

  1983cited by this paper
• Effect of Cyclophosphamide on Immunological Control Mechanisms

  1982cited by this paper
• Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed- type hypersensitivity reactions

  1981cited by this paper
• Adoptive transfer of delayed-type hypersensitivity to Sendai virus. I. Induction of two different subsets of T lymphocytes which differ in H-2 restriction as well as in the Lyt phenotype.

  1981cited by this paper
• An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses

  1981cited by this paper
• Production of DTH in the Mouse to Influenza Virus: Comparison with Conditions for Stimulation of Cytotoxic T Cells

  1980cited by this paper
• Regulation of specific cell-mediated cytotoxic response against SV40- induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

  1979cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• Role of sendai virus fusion-glycoprotein in target cell susceptibility to cytotoxic T cells

  1977cited by this paper
• Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice

  1976cited by this paper
• Studies on the immune response and pathogenesis of Sendai virus infection of mice. III. The effects of cyclophosphamide.

  1975cited by this paper

• Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine

  2007cites this paper
• Immunomodulating anticancer alkylating drugs: targets and mechanisms of activity.

  2001cites this paper
• Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.

  1991cites this paper
• Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

  1991cites this paper